Atlas Trials

Nivolumab and Metformin Hydrochloride in Treating Patients With Stage III-IV Non-small Cell Lung Cancer That Cannot Be Removed by Surgery

Clinical trial NCT03048500 · UNKNOWN

Trial details

NCT number
NCT03048500
Sponsor
Northwestern University
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Recurrent Non-Small Cell Lung CarcinomaStage III Non-Small Cell Lung CancerStage IIIA Non-Small Cell Lung CancerStage IIIB Non-Small Cell Lung CancerStage IV Non-Small Cell Lung Cancer
Start date
2017-07-12
Primary completion
2019-09-19
Enrollment
17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.